Medical Devices

Mexico approves use of high-intensity ultrasound device to treat prostate cancer

Published in Cancer Weekly, August 31st, 2004

The Mexican Ministry of Health has granted approval to U.S. HIFU, a development company based in Charlotte, North Carolina, for the use of the Sonablate 500 in Mexico.

The high-intensity focused ultrasound (HIFU) technology will be used for the treatment of prostate cancer. This is the first HIFU technology officially approved in Mexico.

The Sonablate 500, developed by Focus Surgery Inc., Indianapolis, Indiana, is a noninvasive therapy device that uses the power of ultrasound to destroy deep seated tissue without affecting healthy surrounding tissue. Ultrasound energy is non-ionizing "clean energy" that does not affect tissue surrounding the target...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Cancer Weekly

Source: Cancer Weekly (2004-08-31)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry